Search Results
136 items found for "Wnt pathway inhibition"
- Molecular characterization of breast cancer cell pools with normal or reduced ability to respond to progesterone: a study based on RNA-seq
This resulted in cell pools we termed PR-low as P4 mediated effects were inhibited or blocked compared enriched biological processes affected by PR and associated with G protein-coupled receptor (GPCR) pathways
- The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis
Results: Chidamide (tucidinostat), a novel histone deacetylase inhibitor, was found to have the greatest The use of chidamide in conjunction with BV may positively affect and enhance T-cellular apoptotic pathways
- Session II | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
City, Mexico October 23-25 Download PDF Program HERE < Back to Full Agenda Session II AGPCR signaling pathways oncolytic adenoviruses and anti-angiogenic molecules and is currently developing novel small molecule inhibitors of the hypoxia-inducible factor pathway and the epigenetic reader MBD2 (methyl CpG binding protein 2 Here, I worked on the regulation of the Sonic Hedgehog pathway by GPCRs which localized to the primary
- LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration
< GPCR News < GPCRs in Oncology and Immunology LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced Coexpression of LPA1 with CXCR4 reduced CXCL12-mediated cAMP inhibition, ERK activation, Gαi/o activation LPA or alkyl-OMPT inhibited CXCL12-induced migration in various cancer cells that endogenously express Ultimately, complete inhibition of cell migration toward CXCL12 and alkyl-OMPT was only achieved in the Moreover, our findings propose a therapeutic potential in combined CXCR4 and LPA1 inhibitors for cancer
- From outside to inside and back again: the lysophosphatidic acid-CCN axis in signal transduction
The signaling pathways responsible for LPA/S1P-induced CCN1/2 typically involve activation of the small the extracellular space can facilitate the activation of additional receptors and signal transduction pathways
- Stretch regulates alveologenesis and homeostasis via mesenchymal Gαq/11-mediated TGFβ2 activation
Abstract " Alveolar development and repair require tight spatiotemporal regulation of numerous signalling pathways Mice with constitutive Gαq/11 gene deletion exhibited abnormal alveolar development, with suppressed
- LP2, a cyclic angiotensin-(1-7) analog extended with an N-terminal D-lysine, impairs growth of patient-derived xenografts of colorectal carcinoma in mice
Here, based on strong rationales, we studied the capacity of LP2 to inhibit the growth of patient-derived Subsequent studies demonstrated that LP2 at a subcutaneously injected dose as low as 0.2 µg/kg/day inhibited Kinome analyses and validation of elected kinase inhibition indicated that LP2-mediated AT 2 R stimulation inhibited PI3K/AKT/mTOR which resulted in apoptosis via CDKs. LP2 acted synergistically with 5-FU and the EGFR inhibitor erlotinib.
- Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors
GNAS samples identified by nontargeted proteomics and involved in G protein-coupled receptor (GPCR) pathways The results suggested that GNAS mutations impact endocrinological features in acromegaly through GPCR pathway
- Ep 144 with Dr Aurélien Rizk
Biotech, where he specializes in the development of a technology platform deciphering cell signaling pathways shared about the company's development of a discovery platform for GPCRs and their focus on signaling pathways Rizk also mentioned the interdisciplinary nature of his company, which includes mathematics, signaling pathways ligand and its potential correlation with a therapeutic effect or activation of a specific signaling pathway They emphasized the need to quantify the dynamics of the pathways and the residence time of the receptor
- GPCR Retreat Schedule 2023
: RAMP-interacting GPCR Pathways Inaugural Marc G. Caron Keynote Lecture Kathleen M. Saskatchewan Read More Friday, November 3rd / 11:55 AM Unveiling Non-Canonical Functions for Gαq Signaling Pathways Silvio Gutkind UC San Diego Read More Friday, November 3rd / 3:55 PM Inhibition of Relaxin Autocrine
- Ep 86 with Nicole (Nicki) Perry-Hauser
My long-term research interests involve resolving signaling pathways downstream of aGPCRs and establishing
- Ep 66 with Dr. Antony A. Boucard Jr
alternatively spliced isoforms thus potentially resulting in differential modulation of cell signaling pathways lab highlighted the importance of splicing events in biasing latrophilins’ regulation of cyclic AMP pathways
- Ep 02 with Dr. Terry Hébert
is the angiotensin 1 receptor, especially for its ability to activate a large variety of signaling pathways
- Ep 04 with Dr. Graciela Pineyro
receptors, exploring their signaling, trafficking, and their ability to activate different signaling pathways
- GPCR Retreat 2023 - Part I
Because BAMs engage less well-conserved allosteric sites and exert pathway-specific effects on receptor signaling, they are exciting tools for linking distinct signaling pathways with their physiological Yamamura Endowed Fellowship in Pharmacology, an NIH F32 Postdoctoral Fellowship, and an NIH K99/R00 Pathway
- Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy
dasatinib, saracatinib, the preferential YES1 inhibitor CH6953755, siRNA-mediated knockdown of YES1, Surprisingly, our results also demonstrate that exposure to SFK inhibitors, including dasatinib or knockdown Dasatinib-induced ERK activation was completely abolished by exposure to the FDA-approved MEK inhibitor A combination of dasatinib and trametinib potently and synergistically inhibited colony formation by rationale for considering a combination(s) of FDA-approved SFK (dasatinib) and MEK (e.g., trametinib) inhibitors
- Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
chemokine ligands, activators and antagonists recognize hCCR3, and quantitative measurements of hCCR3 inhibition The study results indicate chemokines interact with hCCR3 at low concentrations, and reversible hCCR3 inhibitors solely inhibit hCCR3, not CCLs.
- Ep 52 with Dr. Benjamin Myers
More recently, Ben’s lab has begun studying GPCR signaling pathways that operate within the primary cilium
- Ep 115 with Dr. Paul J. Gasser
Research in my lab is currently focused on understanding the signal transduction pathways activated by
- Olfactory Receptors and Tumorigenesis: Implications for Diagnosis and Targeted Therapy
This review highlights the specific molecular actions and signaling pathways of olfactory receptors in
- G protein-coupled receptor-mediated signaling of immunomodulation in tumor progression
Here, we discuss the current understanding of the roles of GPCRs and their signaling pathways in tumor
- Ep 141 with Dr Tobi Langenhan
later became Heisenberg Professor for 'Physiology and pathophysiology of mechanoceptive signalling pathways
- Ep 56 with Dr. Adriano Marchese
leveraged this knowledge to reveal the spatial and temporal requirements for GPCR activation of signaling pathways
- Ep 62 with Dr. Sai Prasad Pydi
for the treatment of obesity and Type 2 Diabetes (T2D) by exploring metabolically important signaling pathways
- Ep 45 with Dr Ralf Jockers
Many MT2 variants are biased and their defects are signaling pathway-specific opening new perspectives
- Ep 33 with Dr. David E. Gloriam
His group recently developed an online resource of biased ligands and pathway effects to advance the
- GPR37 promotes colorectal cancer against ferroptosis by reprogramming lipid metabolism via p38-SCD1 axis
modulates lipid metabolism in tumor cells by promoting SCD1 transcription via the MAPK-p38 signaling pathway
- Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling
< GPCR News < GPCRs in Oncology and Immunology Pharmacological inhibition of neuropeptide Y receptors This abundance is exploited for cancer imaging, but there is interest in pharmacological inhibition of receptor positive MCF7 cells were significantly less invasive in 3D spheres when NPY5R was specifically inhibited